Samantha Prout - 02 Jan 2025 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role: Chief Accounting Officer
Signature: /s/ Christian Formica, Attorney-in-Fact
Issuer symbol: FOLD
Transactions as of: 02 Jan 2025
Transactions value $: $-122,127
Form type: 4
Filing time: 06 Jan 2025, 19:06:11 UTC
Previous filing: 16 Apr 2024
Next filing: 13 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FOLD	Common Stock	Tax liability	$-32,054	-3,443	-4.66%	$9.31	70,483	02 Jan 2025	Direct
transaction	FOLD	Common Stock	Award	$0	+34,614	+49.1%	$0.000000	105,097	03 Jan 2025	Direct	F1
transaction	FOLD	Common Stock	Tax liability	$-77,868	-8,275	-7.87%	$9.41	96,822	03 Jan 2025	Direct
transaction	FOLD	Common Stock	Tax liability	$-12,205	-1,297	-1.34%	$9.41	95,525	04 Jan 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FOLD	Stock Options (right to buy)	Award	$0	+62,715		$0.000000	62,715	03 Jan 2025	Common Stock	62,715	$9.41	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 3, 2026 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
F2	These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.